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Quality (AHRQ) comparative effectiveness report on treatments for seasonal aller-
gic rhinitis, which used a non-anchor based approach. Results: Using the most 
conservative estimates provided within the approved prescribing information, the 
change in rTNSS from baseline was -1.18 (p = 0.02) for azelastine hydrochloride, 
-1.35 (p = 0.014) for ciclesonide, -1.47 (p < 0.001) for fluticasone furoate, and -2.7* 
for MP29-02†(p < 0.001). Direct anchor-based estimates of MCID derived by Barnes 
and colleagues ranged from 0.28 units (95% CI: -0.18 to 0.73) and 0.23 units (95% 
CI: -0.16 to 0.62). Comparison of the anchor-based MCID threshold to the observed 
treatment indicates a positive clinical benefit for each treatment option. In con-
trast, the AHRQ report concluded that treatment options were equivalent to each 
other, to intranasal corticosteroids and to placebo, in contrast to common patient 
beliefs. ConClusions: Anchor based methods are critical in evaluating MCID as 
demonstrated by comparison of outcomes across intranasal products for seasonal 
allergic rhinitis. MCID methods need to be considered when evaluating evidence 
for health technology assessments. * Range of rTNSS is 0-12; 0-24 for MP29-02 † 
Dymista® = US trade name of MP29-02
PRM111
Can’t we just use this PoRtuguese tRanslation in bRazil? analysing 
why theRe is MoRe to CountRy-sPeCifiC PRos than tiCking/CheCking 
boxes
Simpson H., Bellhouse G., Neal R., Two R.
PharmaQuest Ltd., Bloxham, UK
objeCtives: It is well established that translations of patient-reported outcome 
(PRO) measures need to be linguistically validated for the country or countries they 
will be used in - whether that means adapting an existing language version for 
use in a new country, or developing a language version for multiple countries from 
the beginning. While it is generally agreed that adaptations must be validated for 
their target countries, we aim to illustrate to stakeholders that there is more to 
this process than just a box-ticking exercise, by exploring the country-specific dif-
ferences that affect translations of PRO measures, and the implications they may 
have for the resulting patient data. Methods: We analysed examples from nearly 
ten years of in-house projects involving the adaptation of existing language ver-
sions for new target countries. A range of wording changes within these adaptation 
projects were identified and categorised according to their nature (linguistic varia-
tions or culturally-bound terms) and their position in the PRO (instruction, item or 
response option). We then further assessed the significance of each change and the 
possible impact on the respondent’s understanding of the measure and their ability 
to answer the items meaningfully. Results: The results of the two-part analysis 
illustrate that although many differences between country-specific language ver-
sions may be considered inconsequential (i.e. if a UK spelling of an English word 
is used in the US, it may still be understood), depending on the type of linguistic 
variation and its prominence within the PRO itself, in some cases there is a real 
risk that without the change an item may be misinterpreted or even impossible to 
answer. ConClusions: The evidence provided by the linguistic and culturally-
bound changes made during in-country adaptation projects emphasises why the 
process of adapting a measure to its target country is invaluable for its successful 
administration.
PRM112
Validation of a Vitality Quotient to MeasuRe the effeCt of food 
suPPleMents on fatigue in healthy subjeCts
Allaert F.1, Courau S.2, Forestier A.2
1Medical evaluation Chair ESC Dijon, Dijon, France, 2Merck CH, Dijon, France
objeCtives: validation of the psychometric properties of the “vitality quotient” 
questionnaire (VQ) i.e. the measures of its internal consistency, external validation 
and sensitivity to change. Methods: Prospective observational survey on patients 
consulting for fatigue and taking Bion3® during winter . The VQ includes 10 ques-
tions describing subjects’ activities and mood, rated from “1: very often” to “10: 
never”. Its comprehensibility and test-retest reliability has been evaluated in one 
other study. Each patient fulfil the VQ and the Pichot scale which is a reference scale 
for fatigue evaluation at inclusion and every month during three months. Internal 
consistency of the QV was measured with Cronbach’s alpha coefficient, external 
validation by its correlation coefficient with Pichot scale and its sensitivity to change 
by the paired T test of its average variations during the study period. Results: 132 
subjects 48.2 ± 13.5 years old (63.6% women) were followed. The Cronbach’s alpha 
coefficient has a very high level of 0.93 and therefore indicates a very good internal 
consistency. The study of the VQ correlation with the fatigue scale of Pichot at 
baseline shows a high Pearson coefficient of r = -0.67 (p < 0.0001) and the study of 
the correlation of their changes during the three months is of r = -0.75 (p < 0.0001). 
The QV is also sensitive to change. After one month the VQ increases from 47.3 ± 
18.5 to 60.4 ± 20.5 and then to 73.5 ± 18.0 after 2 months and to 80.9 ± 18.1 after 3 
months which is highly significant (p< 0,0001) and corresponds to improvements of 
respectively +27.7%, +55.4% and +71.0% of the initial vitality of the subjects taking 
Bion3®. ConClusions: This study validates psychometrics properties (reliability, 
external validity and sensitivity to change) of the « vitality quotient » which appears 
an effective to evaluate food supplements effects in healthy subjects complaining 
of fatigue and expressing a loss of vitality.
PRM113
Challenges faCed duRing linguistiC Validation foR south afRiCa
Towns L., Williams H., Anderson H., Gergovich B.
ICON Plc, Oxford, UK
objeCtives: (1) To investigate the difficulties experienced during translation of 
Clinical Outcomes Assessments for South Africa with regard to the existence of mul-
tiple official languages (2) To identify patterns of terminology usage across different 
settings in South Africa Methods: Back translation and cognitive debriefing reviews 
were reviewed across multiple South African languages from linguistic validation 
projects. The results were compared and challenges with conceptual equivalence 
impacts were described as difficulty standing from a seated position or using stairs 
in early disease followed by increased falls, gait impairment, and progressive loss of 
ambulation resulting in the need for assistive devices. Upper extremity weakness 
results in difficulty with activities requiring gripping and lifting. Dysphagia can 
include swallowing difficulties, choking, and interference with nutritional intake. 
Psychosocial impacts were often related to the loss of autonomy, fear of falls, social 
and familial impacts and the need for assistance. ConClusions: This sIBM disease 
model adds significantly to the literature describing the patient impact of sIBM and 
may be used to guide selection of clinical trial endpoints.
PRM108
health-Related Quality of life aMong esRf Patients in Pakistan: a 
CRoss-seCtional aPPRoaCh using whoQol-bRef
Iqbal M.Z.1, Iqbal M.S.2, Iqbal M.W.3, Bahari M.B.2, Nasir S.4
1Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 
Pulau Pinang, Malaysia Department of Clinical Pharmacy & Pharmacy Practice, Faculty of 
Pharmacy, AIMST University, Kedah, Malaysia, 2Department of Clinical Pharmacy & Pharmacy 
Practice, Faculty of Pharmacy, AIMST University, Kedah, Malaysia, 3Faculty of Law, University of 
Malaya, Kualalumpur, Malaysia, 4Nishtar Hospital, Multan, Pakistan
objeCtives: To evaluate health-related quality of life (HRQoL) of End Stage Renal 
Failure (ESRF) patients in Pakistan. Methods: A prospective cross-sectional study 
was conducted at a tertiary care hospital in a province of Pakistan, the Punjab. 
WHOQOL-BREF (Urdu version, pretested for reliability and validity) was used as 
research instrument. Data was obtained through face-to-face interviews and where 
possible by gender-based focus group sessions. WHOQOL-BREF score was obtained 
and evaluated to determine HRQoL of ESRF patients. Patients were also asked 
to share their personal experiences of being diagnosed and treatment given. All 
obtained data were analyzed using descriptive and inferential statistics by using 
SPSS 20.0. Results: The overall Cronbach’s alpha coefficient of the revalidated 
WHOQOL-BREF questionnaire was 0.799. The scores for negative feelings, depres-
sion, living place, personal relationships and sexual life were significantly different 
in the psychological health and social relations domains. Mean age, gender, educa-
tion level, occupation and physical exercise were also significantly associated with 
the HRQoL of the ESRF patients. ConClusions: The WHOQOL-BREF was a reliable 
and valid research tool to evaluate HRQoL of ESRF patients in Pakistan. A significant 
impact on HRQoL of the ESRF patients was observed. Together with curative and pre-
ventative measures, there is also a great need to measure HRQoL of ESRF patients.
PRM109
Challenges in tRanslating the ConneRs 3Rd edition–PaRent into 12 
languages
Verne A., Bailly C., Rouillat C.
Mapi, Lyon, France
objeCtives: The Conners 3rd Edition–Parent (Conners 3–P) is used to obtain par-
ents’ observations about the behaviors and feelings of children and adolescents 
aged 6-18 years old. Developed in American English and published by Multi-Health 
Systems, it was designed to assess Attention Deficit/Hyperactivity Disorder 
(ADHD). The short version provides the evaluation of inattention, hyperactivity/
impulsivity, learning problems, executive functioning, aggression, and peer rela-
tions, and includes 43 items rated on a 4-point scale (“Not true at all” to “Very 
much true”). The objective of this study is to present the challenges faced during 
the translation of the instrument into ten Indo-European languages (English for 
four countries, French, Italian, German, Spanish for three countries), one Sino-
Tibetan (Chinese), and one Austronesian language (Malay). Methods: The fol-
lowing translation method was used: 1. Concept definition; 2. Forward/backward 
translation [or adaptation for English and Spanish versions (i.e., for Argentina 
and Mexico)]; 3. Review of the back-translations/adaptations by the copyright 
holder of the instrument; and 4. Cognitive interviews with five parents in each 
country. Results: The translation process did not reveal any cultural issues since 
most of the concepts assessed were cross-culturally relevant. The main difficul-
ties consisted in finding conceptual equivalents of the original items with strong 
idiomatic content. For instance, the most challenging items were items 13 (“Acts 
as if driven by a motor”), 31 (“Tells the truth; doesn’t even tell “little white lies.”), 
and 40 (“Behaves like an angel”). Most of the solutions were found using concept 
definitions. Parents were important in discussing changes or proposing solu-
tions. Examples will be provided. ConClusions: The multi-step process proved 
to be critical to ensure the production of conceptually equivalent and culturally 
appropriate translations of the Conners 3–P into Indo-European, Sino-Tibetan and 
Austronesian languages. The involvement of the copyright holder and of parents 
was crucial in finding solutions.
PRM110
the iMPoRtanCe of anChoR based MiniMal CliniCally iMPoRtant 
diffeRenCe (MCid) to health teChnology assessMent of established 
intRanasal alleRgiC Rhinitis tReatMents
Brixner D.1, Meltzer E.O.2, Morland K.3, Carroll C.A.3, Lipworth B.J.4
1University of Utah, Salt Lake City, UT, USA, 2Allergy and Asthma Medical Group and Research 
Center, San Diego, CA, USA, 3Xcenda, Palm Harbor, FL, USA, 4Ninewells Hospital and School of 
Medicine, Dundee, UK
objeCtives: Anchor based methods are commonly used to derive MCID in treat-
ment assessments. The objective of this work was to compare the outcomes of 
an anchor-based vs. non-anchor based methodology in the health technology 
assessment of intranasal allergic rhinitis treatments. Methods: Data specific to 
the treatment benefit (active drug versus vehicle placebo) of 4 intranasal seasonal 
allergic rhinitis treatments (azelastine hydrochloride, ciclesonide, fluticasone furo-
ate, MP29-02) using the reflective Total Nasal Symptom Score (rTNSS) were obtained 
from the FDA approved prescribing information. Anchor-based MCID estimates 
reported from Barnes et al. 2010 were then compared to the treatment effect. The 
outcomes were then compared to the July 2013 Agency for Healthcare Research & 
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individuals caring for visually impaired patients remains unknown. The study objec-
tive is to outlook the instruments currently available for measuring caregiver burden 
for visually impaired patients and to identify whether linguistic validation has been 
done in Japan. Methods: We performed a literature review on articles describing 
instruments of caregiver reported outcomes for eye disorders. We summarized the 
current evidence on the usefulness of the instruments and whether they differentiate 
between eye diseases and other non-eye related diseases. In addition, we investigated 
possible hurdles in measuring caregiver burden in eye disorders, given the environ-
mental understandings of patients with visual impairments and their caregivers in 
Japan. Results: We identified two caregiver burden measurements, one depression 
measurement, and one life-satisfaction scale used in studies for measuring caregiver 
outcome for patients with visual impairments. A few studies using these instruments 
demonstrated correlation between the degree of caregiver burden and/or level of 
depression and severity of visual impairments. Excluding one caregiver burden instru-
ment, Japanese versions of the remaining three instruments have been developed and 
validated. However, realistic use of these instruments are still questionable because: 
1) most of the patients with visual impairments in Japan are elderly and increased 
caregiver burden may be due to conditions associated with older age, and 2) aging 
of caregivers are also progressing, resulting in increased perceived caregiver burden 
to support the patients. ConClusions: Evidence is limited when measuring the 
impacts of eye diseases on their caregivers. Further research is required to identify 
the usefulness of these instruments to measure caregiver burden for patients with 
eye diseases in Japan.
PRM117
deVeloPMent of eleCtRoniC diaRy in Patients with PRiMaRy biliaRy 
CiRRhosis
Gilchrist K., Vallow S.
GlaxoSmithKline, King of Prussia, PA, USA
objeCtives: Primary biliary cirrhosis (PBC) is a disease with chronic symptoms such 
as fatigue and itching. To characterize the varied symptoms of PBC and evaluate ben-
efits of new PBC treatments, an electronic diary (e-diary) was developed. Methods: 
E-diary items were developed based on PBC-40 (health related questionnaire devel-
oped for PBC), other pruritis questionnaires and clinical consult. Concept elicita-
tion interviews were conducted with PBC patients from the UK to further confirm 
PBC symptoms, symptom characteristics, impact and relevance. PBC patients with 
ongoing or previous (< 2 years) symptoms participated. Cognitive debriefing of the 
diary was conducted with the e-diary format and confirmed usability. In addition, the 
interview evaluated the PBC-40 as 4 week recall period to determine feasibility of 1 
week recall. Results: 10 PBC subjects participated mean age 54.1, +12.9 years; 9/10 
subjects were women. Subjects commonly reported experiencing itch, fatigue, and 
impacts on sleep, confirming importance for inclusion in the e-diary. Frequency of 
itch and fatigue also varied, supporting frequent capture. Subjects reported e-diaries 
were relevant, appropriate and could be easily used for symptom reporting. Interviews 
focusing on PBC-40 recall period supported the change from “past 4 weeks” to “past 1 
week.” ConClusions: Capture of PBC symptoms such as itch and other symptoms 
of PBC that vary frequently in an e-diary, and usability of the e-diary, was supported 
through interviews with PBC patients. Symptom characterization of itching could be 
further refined. Funding for this study was provided by GlaxoSmithKline
PRM118
assessMent of tReatMent adheRenCe and Quality of life in diabetiC 
Patients tReated with insulin in two ColoMbian Cities
Medina Morales D.A., Machado Alba J.E., Echeverry-Cataño L.F., Londoño-Builes M.J.
Universidad Tecnológica de Pereira, Pereira, Colombia
objeCtives: Diabetes mellitus is a public health problem and its influence is rec-
ognized in the quality of life of patients. According to WHO, only 50% of people have 
adherence to treatment of chronic diseases. This study evaluated and compared 
the results of the scales measuring quality of life and adherence to treatment in 
two groups of patients with diabetes and treatment with conventional or analogue 
insulins Methods: Cross-sectional study in two groups of patients diagnosed 
with diabetes mellitus type 1 or type 2, in medical treatment with conventional or 
analogues insulines, for at least six months in two cities in Colombia. The sample 
was calculated with a ratio of 0.5-Control Group, with estimated RR of 0.75 and 
allocation rate between groups of 0.5. Each patient responded two scales measuring 
quality of life (EQ-5D and Diabetes-39) and two scales measuring adherence (Morisky 
Green and Medication Possession Ratio) and comparison was made between the 
results obtained. Results: 240 patients with a mean age of 57.7 ± 16.6 years were 
included, 69.6% were prescribed whit conventional insulin and 30.4% with ana-
logues insulin. 68.3% of patients were adherent to medical therapy and only 7.1% 
(n = 17) had high quality of life. Patients more than 60 years were less likely to have 
high quality of life (OR: 0.177; 95% CI 0.050 to 0.635; p = 0.003), while adherence 
was less likely in patients aged 31-45 years (OR: 0.427; 95% CI 0.187 to 0.971; p = 
0.038). ConClusions: The quality of life and treatment adherence is significantly 
affected in patients with diabetes mellitus, which may also impact its metabolic 
control. It is necessary to establish individual and group interventions to improve 
these conditions in patients.
PRM119
iMPoRtanCe of the ConCePtual definition of PRo MeasuRes: a 
Case study with the linguistiC Validation of the iRRitable bowel 
syndRoMe Quality of life (ibs-Qol) instRuMent in 17 asiatiC 
languages
Lambe J.1, Patrick D.L.2, Toraubully N.1, Skerritt B.3, Acquadro C.4
1Mapi, Lyon, France, 2University of Washington, Seattle, WA, USA, 3ICON, Dublin, Ireland, 4Mapi 
Research Trust, Lyon, France
objeCtives: The Irritable Bowel Syndrome Quality of Life Instrument (IBS-QOL) 
is a self-report measure developed to assess the impact of IBS and its treatment. 
The instrument contains 34 items, rated on a five-point scale. The IBS-QOL was 
were noted. In addition the 2011 South African Census was reviewed. Results: The 
2011 census revealed, of 11 official languages, English is the most common ‘everyday’ 
language in business, politics and the media. However, it’s not the most common lan-
guage spoken at home. This inconsistency causes translation issues for the following 
reasons: (1) English names are commonly used for diseases and drugs, as these are 
referred to in ‘home’ languages with varying localised terms/descriptions (2) There 
is not the same broad vocabulary in the ‘home’ languages, due to the prevalence 
of English outside of the home, so descriptions are often used to reflect the source 
wording (3) Attitudes towards biomedicine can be subject to cultural differences in 
South Africa so certain concepts have to be localised and may appear to differ sig-
nificantly from the source (4) ‘Home’ languages are not often written so have evolved 
erratically, with different linguists having different opinions on spelling and gram-
mar ConClusions: This distinction between the ‘everyday’ language used in work, 
education, etc. and the ‘home’ languages causes difficulties with linguistic validation 
for South Africa. Linguists disagree on the general use of the languages which seems 
to be constantly changing. However, while the translation issues are multiple and 
varied the linguistic validation process appears to provide the resolutions, where all 
source wording is translated, reviewed, questioned and discussed in order to find a 
conceptual equivalent rather than a literal translation.
PRM114
ReCoMMendations foR the linguistiC Validation of PediatRiC 
CliniCal outCoMes assessMents
Gawlicki M.1, Brandt B.1, McKown S.1, Talbert M.2
1Corporate Translations Inc, East Hartford, CT, USA, 2Corporate Translations Inc, Chicago, IL, USA
objeCtives: The objective of this study was to test cognitive debriefing strategies 
for translated Clinical Outcomes Assessments (COA) intended for pediatric popula-
tions. Methods: Two questionnaires were translated into 11 languages, each for a 
specific pediatric population. One was an assessment on the palatability of medi-
cation, intended for ages 6-12. It was hypothesized that probe questions would be 
more effective for cognitive debriefing subjects aged 6-12. Subjects were asked how 
they would respond to the questionnaire in hypothetical conditions to demonstrate 
comprehensibility of the translated text. The second questionnaire contained visual 
analog scales (VAS) to assess pain for those aged 13-18. It was hypothesized that 
paraphrasing without supplementary probes, as used for adult subjects, would suf-
ficiently determine comprehensibility for this age group. Results: The palatability 
assessment was debriefed on 55 subjects with an average age of 9, and a standard 
deviation of 1.9. According to the results, the subjects showed probes were deemed 
to be a success with the younger sample, as they demonstrated their ability to under-
stand how to respond to the questionnaire. The pain VAS scales were debriefed on 50 
subjects with an average age of 15 and a standard deviation of 1.4. Results indicated 
that probes were not necessary if the nature of the questionnaire did not warrant 
them for subjects of any age. Paraphrasing definitively demonstrated comprehension 
by subjects aged 13-18. ConClusions: The results of cognitive debriefing data in 
this study show that probing is a viable method for cognitive debriefing of translated 
COAs with subjects aged 6-12 years old. For questionnaires intended for a population 
for 13-18 years of age, paraphrasing should sufficiently determine comprehension, 
as was demonstrated in this study, the same method that is used for adult subjects.
PRM115
use of woRk PRoduCtiVity endPoints in CliniCal studies: a ReView by 
disease state and MeasuReMent tyPe
Popelar B., Walters T., Zagadailov E.A., Houle C., Duhig A.
Xcenda, Palm Harbor, FL, USA
objeCtives: Productivity outcomes are of interest because they describe the con-
sequence of disease in the workplace and impact on productivity. We conducted 
an analysis of work productivity (WP) endpoints in clinical studies. Methods: 
A keyword search was conducted on Clinicaltrials.gov for “work productivity” to 
identify relevant studies. Trials with terminated, withdrawn, or suspended sta-
tus, those with non-drug interventions, and those without WP endpoints were 
excluded from analysis. A total of 170 studies were included (113 interventional 
and 57 observational studies). Results: Of the 170 studies included, 44% were 
performed outside of the US, 31% were multinational studies including the US, 
and 25% were conducted exclusively in the US. The most common therapeutic 
categories investigated were autoimmune diseases (37%), neurology (14%), and 
psychiatry (9%). Most studies (84%) were sponsored by pharmaceutical manu-
facturers, with 11% sponsored by other institutions, or a combination of both 
(6%). The majority of trials investigated WP as a secondary measure (89%), with 
several, primarily observational studies, reporting WP as a primary outcome (11%). 
Survey instruments were utilized most commonly, representing 82% of studies, 
while 9% of studies evaluated WP based on time missed from work. Some studies 
utilized multiple measures. Generic instruments, such as the Work Productivity 
and Activity Impairment Questionnaire (WPAI), were used in 54% of studies, while 
29% used disease-specific measures. In some cases (15%) a specific tool or instru-
ment for WP was not identified. Most trials (93%) included other patient-reported 
endpoints, in addition to WP. ConClusions: WP endpoints were most commonly 
investigated in manufacturer-sponsored trials as secondary outcomes to demon-
strate patient benefit in therapeutic areas where more concrete clinical outcomes 
are limited. Generic instruments are heavily utilized, with approximately one-third 
of studies utilizing disease specific measures.
PRM116
ReView of CaRegiVeR buRden sCales foR Patients with Visual 
iMPaiReMent in jaPan
Narimatsu A., Ishii K., Adachi K.
Bayer Yakuhin Ltd., Tokyo, Japan
objeCtives: Among the societal costs of visual impairment in Japan, cost of both 
unpaid and paid home care for people with visual impairment has been estimated 
as a substantial component of indirect cost. However, the degree of burden among 
